KLRA is trading at $22.65 (up 6%), rebounding from the prior session’s pullback and continuing its highly volatile post-IPO trading pattern.

  • The stock has remained highly active following its $625 million IPO at $16 per share and subsequent Nasdaq debut within the high-growth obesity and weight-loss space.
  • There are no fresh company-specific headlines or regulatory filings on June 24, 2026, to account for the move, though a modestly higher broader market is providing a supportive backdrop.